Observational Study of Women with Endometrial Cancer Receiving Standard Surgery Including Hysterectomy and Sentinel Lymph Node Biopsy

What this Trial Is About

Researchers are studying women diagnosed with endometrial cancer to understand how often the cancer returns after receiving standard treatment and to monitor the occurrence of lymphedema, a potential side effect. The study focuses on patients with endometrioid adenocarcinoma undergoing surgery including hysterectomy and sentinel lymph node biopsy, aiming to track outcomes over time. Participants will have surgery involving hysterectomy, bilateral salpingo-oophorectomy, and sentinel lymph node mapping confirming no malignancy in the lymph nodes. After surgery, those in the study cohort will be followed clinically for relapse with physical exams at post-operative visits for up to 30 months. During the study, participants will undergo regular physical examinations and clinical follow-up visits to check for cancer recurrence and monitor for lymphedema. Researchers will measure the incidence of pelvic or non-vaginal cancer recurrence within 36 months. Participants will be observed for up to 30 months after surgery, with detailed monitoring of symptoms and outcomes throughout the follow-up period.

Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease